L-Carnitine-supplementation in advanced pancreatic cancer (CARPAN)--a randomized multicentre trial.

Background: Cachexia, a >10% loss of body-weight, is one factor determining the poor prognosis of pancreatic cancer. Deficiency of L-Carnitine has been proposed to cause cancer cachexia.Findings: We screened 152 and enrolled 72 patients suffering from advanced pancreatic cancer in a prospective, mul...

Descripción completa

Detalles Bibliográficos
Publicado en:Nutrition Journal Vol. 11; pp. 52 - 53
Autores principales: Kraft, Matthias, Kraft, Kathleen, Gärtner, Simone, Mayerle, Julia, Simon, Peter, Weber, Eckhard, Schütte, Kerstin, Stieler, Jens, Koula-Jenik, Heide, Holzhauer, Peter, Gröber, Uwe, Engel, Georg, Müller, Cornelia, Feng, You-Shan, Aghdassi, Ali, Nitsche, Claudia, Malfertheiner, Peter, Patrzyk, Maciej, Kohlmann, Thomas, Lerch, Markus M
Formato: research randomized controlled trial Journal Article
Publicado: BioMed Central 2012
Acceso en línea:Ver este registro en EBSCOhost